Unichem Laboratories Limited (BOM:506690)
384.60
-2.35 (-0.61%)
At close: Feb 12, 2026
Unichem Laboratories Market Cap
Unichem Laboratories has a market cap or net worth of 27.08 billion as of February 13, 2026. Its market cap has decreased by -47.40% in one year.
Market Cap
27.08B
Enterprise Value
30.16B
Revenue
22.14B
Ranking
n/a
PE Ratio
9.20
Stock Price
384.60
Market Cap Chart
Since July 30, 2001, Unichem Laboratories's market cap has increased from 5.81B to 27.08B, an increase of 366.28%. That is a compound annual growth rate of 6.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 27.08B | -12.86% |
| Dec 31, 2025 | 31.07B | -40.43% |
| Dec 31, 2024 | 52.16B | 82.07% |
| Dec 29, 2023 | 28.65B | 28.87% |
| Dec 30, 2022 | 22.23B | 27.19% |
| Dec 31, 2021 | 17.48B | -5.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 63.50B |
| Gufic Biosciences | 31.49B |
| Hikal | 23.58B |
| Bliss GVS Pharma | 22.67B |
| Morepen Laboratories | 21.73B |
| Novartis India | 20.50B |
| Shukra Pharmaceuticals | 19.47B |
| Amrutanjan Health Care | 18.66B |